Real world data evidence on cancer patients awareness and knowledge of cancer associated thrombosis (CAT) events
Real-world behavioral restrictional practices of cancer patients (pts)
Lessons Learned from the Implementation of a Person-Centred Digital Health Platform in Cancer Care
Covid 19 infection leading to a subsequent new primary cancer diagnosis, Real-world data (RWD) analysis on members of Belong.life, a global cancer application
esearched by Belong.Life and published by ASCO Some known viral infections can lead to a diagnosis of cancer (e.g: HPV, HIV, EBV, etc.) Anecdotical reports of a Covid 19 infection, and the subsequent diagnosis of a new cancer have been mentioned by few patients (pts). This relationship has not yet been fully documented. Covid 19 […]
The prevalence of Cannabis-related arrhythmias
Avishag Laish-Farkash, MD PhD, Luba Vasilenko, MD, Noy Moisa, BSc, Daniel Vorobiof, MD The prevalence of Cannabis-related arrhythmias – Real world data evidence (RWDE) and patient’s reported outcomes (PRO) by using BELONG.life digital application (app).he prevalence of Cannabis-related arrhythmias – Real world data evidence (RWDE) and patient’s reported outcomes (PRO) by using BELONG.life digital application […]
Fatigue Prevalence And Adherence To Treatment: A Real-World Data Survey And Mathematical Model Application
Researched by Belong.Life and published by ESMOFatigue is a common symptom reported by cancer patients (pts) and has been previously documented to affect patient’s quality of life. A real-world data survey was designed to evaluate, from the pts perspective, the fatigue effect and treatment adherence. The survey was created in a digital format. This was […]
Identifying The Patient Journey And Treatment Lines Patterns In Metastatic Pancreatic Cancer
Researched by Belong.Life and published by ASCOIdentifying the patient journey and treatment lines patterns in metastatic pancreatic cancer Data from patients using the Belong PPN was able to provide insights into the treatment journeys of MPC patients in Israel, the four firstline treatment prevalence and the following lines of treatment. Continuous evaluation of RWE and […]
Mapping PD-1 Inhibitors’ Side Effects Using Patient Reported Outcomes
Researched by Belong.Life and published by ASCOData from the Belong PPN successfully captured the spectrum of PD-1 inhibitors’ reported AEs. Analyzing PRO of post approval treatments could provide deeper understanding of treatment patterns, expose limiting AE that bear implications on cost of treatment, indicate patients’ quality of life (QOL), improve management recommendations and provide a […]
Unveiling The Real-World Outcomes Of Breast Cancer Patients With Taxanes-Induced Neuropathy Using A Digital Patient-Powered Network
Researched by Belong.Life and published by ASCOTaxanes-induced neuropathy is common in BC patients receiving taxanes, forcing dose reductions and treatment delays and posing serious challenges for the long-term patient QoL. Discovering neuropathy predictors in patients could guide better treatment decisions, improved QoL and reduce healthcare costs. Belong digital PPN is a social network for cancer […]
Creating The Real-World Medical Record: Using Digital Patient-Generated Data To Create An Updated Picture Of Patients Outcomes
Researched by Belong.Life and published by ASCOValue-based healthcare requires integration of real-world data (RWD) generated by patients in parallel to clinical documentation. This gives a holistic perspective of the patients’ health and care and could lead to reduced costs and better patient care and safety. Belong digital patient-powered network (PPN) is a social network for […]
Patients Reported Outcomes In Breast Cancer: Physical, Emotional Side Effects, Financial Toxicity, And Complementary Usage Relations
Researched by Belong.Life and published by ASCORWD denotes data accumulated via electronic health records as well as cutting edge technology paired with consumer mobile devices. Artificial intelligence (AI) incorporates the use of algorithms and machine learning (ML) software to analyze complex medical data, improving the knowledge of cancer journeys. PRO on 256 BC patients (pts) […]
Advanced Breast Cancer Patients, Focusing On Patient’s Reported Outcomes In Reducing The Burden Of Financial Toxicity
2019 Researched by Belong.Life, Published by the The Breast. A targeted survey of Belong.life Advanced Breast Cancer (ABC) patients (pts), focusing on patient’s reported outcomes (PROs), real world evidence (RWE) and insights in reducing the burden of financial toxicity (FT) Background: 151 ABC pts, active Belong.life users, the world largest, anonymous and free social media […]
Pilot Implementation of a Person-Centered E-Health Platform in Gynecological Cancer Care
2019Researched By Belong.Life with JGH and Presented by McGill UniversitySee the latest study that was conducted by McGill University and the Jewish General Hospital in Toronto, Canada, using the Belong.life platform. To the research>
Financial Toxicity In Cancer Patients Receiving Immunotherapy
Researched by Belong.Life and published by ESMOKey Study to be Presented at ESMO Virtual Congress 2020 Shows Nearly Half of Patients Receiving Immunotherapy are Unaware of Possible Financial Toxicity (FT) Research Demonstrates Importance of Engaging Patients Throughout the Cancer Journey, Suggests Physicians Discuss FT from Moment of Diagnosis. To the research>
Financial Toxicity in American Patients Receiving Cancer Immunotherapy Drugs
Researched by Belong.Life and published by ASCOKey Findings: Financial toxicity is most prevalent in American patients older than 61. Half of those patients were unaware of possible issues of financial toxicity and only 29.3% received pre-treatment FT advice from their doctors. Those who did receive advice saw a 41% reduction in financial toxicity incidence. To […]
Physician’s Advice On BRCA Genetic Testing For Ovary And Breast Cancer Patients
Researched by Belong.Life and published by ASCOKey Findings : BRCA testing should be recommended for all pts with recently diagnosed BC and OC and in those with a higher chance of having a mutation, as defined by the USPSTF guidelines. In this RWD evaluation of Belong.life BC and OC pts, BRCA testing in BC was […]
